Fact CheckerSign in

NCT05735340Completed

Type 1 Diabetes Education and Support Study

Evaluating the Feasibility of Type 1 Diabetes Education and Support Intervention to Improve Diabetes Distress Among Black Young Adults

Source: ClinicalTrials.gov · Last updated 6 May 2026

Brief summary (registry, in English)

Diabetes distress has been identified as one of the largest contributors to the racial disparity in glycemic control that disproportionately burdens Black patients ages 18-30 years with type 1 diabetes (T1D). In order to combat this issue, this study assesses the feasibility of the culturally tailored intervention T1DES and evaluates the effect of the T1DES intervention on diabetes outcomes in a pilot randomized clinical trial among Black young adults with T1D.

Status (registry)
Completed
Study type
Interventional
Enrollment
43 (actual)
First submitted
30 Jan 2023
Start date
15 Apr 2023
Primary completion date
6 Feb 2026
Lead sponsor
Kaiser Permanente
NCT number
NCT05735340

What you commit to

  • Study type: Interventional
  • Participants enrolled: 43
  • From 15 Apr 2023 to the primary completion date, 6 Feb 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Developmental delay or other cognitive impairment that would render the participant unable to provide informed consent
  • Subjects with visual impairment or have severe hearing or other physical disabilities that would be a barrier for participating in-group or web sessions
  • Diabetes complications that would preclude participation in the study

Who the study is looking for

  • Kaiser Permanente Georgia Member
  • Aged 18 - 30 years
  • Confirmed diagnosis of Type 1 diabetes
  • Hemoglobin A1c \> 7.5 at time of enrollment
  • a cell phone able to send/receive text messages
  • Self-reported race of Black or African American
  • Ability to read in English and provide informed consent

Age in the registry: 18 years to 30 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Kaiser Permanente Georgia
Coordinator of this site? Confirm its status
AtlantaUnited StatesUnknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.